↓ Skip to main content

Genetic contribution to mesenchymal stem cell dysfunction in systemic lupus erythematosus

Overview of attention for article published in Stem Cell Research & Therapy, May 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter
7 X users
googleplus
1 Google+ user

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
30 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Genetic contribution to mesenchymal stem cell dysfunction in systemic lupus erythematosus
Published in
Stem Cell Research & Therapy, May 2018
DOI 10.1186/s13287-018-0898-x
Pubmed ID
Authors

Yantong Zhu, Xuebing Feng

Abstract

Allogeneic mesenchymal stem cell (MSC) transplantation has recently become a promising therapy for patients with systemic lupus erythematosus (SLE). MSCs are a kind of multipotent stem cell than can efficiently modulate both innate and adaptive immune responses, yet those from SLE patients themselves fail to maintain the balance of immune cells, which is partly due to the abnormal genetic background. Clarifying genetic factors associated with MSC dysfunction may be helpful to delineate SLE pathogenesis and provide new therapeutic targets. In this review, the scientific evidence on the genetic contribution to MSC dysfunction in SLE is summarized.

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 30 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 13%
Student > Doctoral Student 3 10%
Researcher 3 10%
Student > Master 3 10%
Student > Bachelor 2 7%
Other 5 17%
Unknown 10 33%
Readers by discipline Count As %
Medicine and Dentistry 10 33%
Veterinary Science and Veterinary Medicine 3 10%
Biochemistry, Genetics and Molecular Biology 3 10%
Agricultural and Biological Sciences 1 3%
Unspecified 1 3%
Other 2 7%
Unknown 10 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 June 2018.
All research outputs
#4,662,096
of 23,072,295 outputs
Outputs from Stem Cell Research & Therapy
#472
of 2,436 outputs
Outputs of similar age
#90,478
of 330,346 outputs
Outputs of similar age from Stem Cell Research & Therapy
#10
of 66 outputs
Altmetric has tracked 23,072,295 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,436 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 330,346 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 66 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.